Crossmark

E2F1 proteolysis via <scp>SCF</scp> ‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition

Crossref DOI link: https://doi.org/10.15252/embj.2018101443

Published Online: 2019-08-19

Published Print: 2019-10-15

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Burdova, Kamila

Yang, Hongbin

Faedda, Roberta

Hume, Samuel

Chauhan, Jagat

Ebner, Daniel

Kessler, Benedikt M

Vendrell, Iolanda

Drewry, David H

Wells, Carrow I

Hatch, Stephanie B

Dianov, Grigory L

Buffa, Francesca M

D'Angiolella, Vincenzo https://orcid.org/0000-0001-8365-9094
Funding

Funding for this research was provided by:

Medical Research Foundation (MC_UU_00001/7)

John Fell Fund, University of Oxford (133/075)

Wellcome Trust (097813/Z/11/Z)

National Institutes of Health (1R44TR001916‐02, 1R01CA218442‐01, U24DK116204‐01)

Cancer Research UK (C5255/A18085)
License Information

Version of Record valid from 2019-08-19
More Information

Publication History

Received: 2019-01-01

Accepted: 2019-07-29

Published: 2019-08-19